Clinical Trials Logo

Filter by:
NCT ID: NCT05020210 Enrolling by invitation - ARDS Clinical Trials

Effect of Early Treatment With Sivelestat Sodium in ARDS Patients

siv-ARDS
Start date: September 30, 2021
Phase:
Study type: Observational

This study is a multicenter, prospective, observational cohort study. The subjects were patients who developed ARDS within the preceding 72h. They were divided into 2 groups based on the use of sivelestat sodium which was determined by the physician in charge based on the condition of the patients: sivelestat sodium group and conventional treatment group. 560 patients were planned to be enrolled, with 280 patients in each group. In the sivelestat sodium group, patients were treated with sivelestat sodium within 72h of the diagnosis of ARDS. After 5 days of sivelestat treatment, sivelestat treatment should be stopped if the oxygenation index is greater than 300mmHg for at least 3 consecutive times; otherwise, sivelestat treatment should be continued until the oxygenation index is greater than 300mmHg for at least 3 consecutive times; if sivelestat treatment is continued until the 14th day, the drug should be stopped regardless of the oxygenation situation. Baseline data and Murray lung injury score, inflammatory markers, routine test results, duration of ECMO use/length of hospital stay/length of ICU stay were recorded at 1, 3,5, and 7 days after patients were enrolled, and patients were followed up on the 28th and 90th days.

NCT ID: NCT05015686 Enrolling by invitation - Varicella Clinical Trials

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Start date: September 30, 2021
Phase: Phase 3
Study type: Interventional

This a randomized, blind, controlled clinical trial of live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd .The purpose of this study is to evaluate the immunogenicity of a two doses vaccination of investigational vaccine with 0,28 day, 0,42 day and 0,56 day immunization schedule in population aged ≥13 years old.

NCT ID: NCT05011214 Enrolling by invitation - Sevoflurane Clinical Trials

Comparison of Sedation by Esketamine and Sevoflurane

Start date: September 20, 2021
Phase: Phase 4
Study type: Interventional

Pediatric diseases,including congenital cataract,,corneal injury,corneal ulcer, usually need suture removal and ophthalmic examination after Surgery for several days. Unfortunately, it remains a great challenge to achieve successful sedation due to children's noncooperation. Sevoflurane is one of the most often used anesthesia agents to provide deep sedation. Although sevoflurane has been used for pediatric anesthesia with successful keep spontaneous breathing without intubation, it should be noted that sevoflurane often results in air pollution under the open airway background and postoperative agitation. Esketamine is the S (+) isomer of ketamine, which produces a dissociated state with minimal risk of airway compromise or apnea. It has enhanced analgesic potency and faster elimination compared to ketamine. However, it may also cause delirium during the recovery time. Based on these experiences on ketamine, we compared the effectiveness of esketamine and sevoflurane for short ophthalmological procedure in pediatric patients.

NCT ID: NCT05007587 Enrolling by invitation - Clinical trials for Hepatocellular Carcinoma Stage IIIa

Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC

Start date: July 1, 2021
Phase: Early Phase 1
Study type: Interventional

Lenvatinib Plus Hepatic Arterial Infusion of Modified FOLFOX Regime vs Lenvatinib Plus Hepatic Arterial Infusion of Oxaliplatin Plus Raltitrexed in Patients with Advanced Hepatocellular Carcinoma

NCT ID: NCT05004246 Enrolling by invitation - Prognosis Clinical Trials

Longitudinal Changes in Characteristics of COVID-19 Survivors and Their Long-term Follow-up Study

Start date: March 15, 2021
Phase:
Study type: Observational

Follow-up study of Coronavirus disease 2019 (COVID-19) survivors has rarely been reported. We aimed to investigate longitudinal changes in the characteristics of COVID-19 survivors after discharge.

NCT ID: NCT04997850 Enrolling by invitation - Clinical trials for Hepatocellular Carcinoma Non-resectable

The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma

Start date: May 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

We adopted the prospective cohort study to compare the safety and efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody in the treatment of advanced unresectable liver cancer.The purposes of our study include:1. Primary objective: To compare the safety and efficacy of TACE combined with Lenvatinib and PD-1 antibody versus TACE alone in the conversion-resection of patients with advanced unresectable hepatocellular carcinoma.2. Secondary objective: To compare the long-term outcome of TACE combined with Lenvatinib and PD-1 antibody versus TACE alone for patients with advanced unresectable hepatocellular carcinoma.

NCT ID: NCT04996953 Enrolling by invitation - Insomnia Chronic Clinical Trials

The Correlation Study of Hypnotic Drugs on the Cognitive Function of Patients With Chronic Insomnia.

Start date: June 1, 2021
Phase:
Study type: Observational

All the subjects were assessed for sleep quality, anxiety and depression, and cognitive function. Based on their previous hypnotic medication history, they were divided into a non-medicine group and a benzodiazepine group,and the group taking non-benzodiazepine drugs.The cognitive effects of different hypnotic drugs on patients were evaluated by comparing sleep related scale and cognitive function scale.

NCT ID: NCT04992806 Enrolling by invitation - Clinical trials for Femoroacetabular Impingement

A Retrospective Study on the Effect of Surgery on Hip Diseases

Start date: June 1, 2020
Phase:
Study type: Observational

To study the effect of arthroscopy on the treatment of hip diseases and to evaluate the regularity and treatment of hip joint diseases.

NCT ID: NCT04991909 Enrolling by invitation - Pain Clinical Trials

A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects

Start date: August 23, 2021
Phase: Phase 1
Study type: Interventional

The study is being conducted to assess the safety and tolerability of HRS4800 after multiple oral administration with different dose regimens in healthy subjects.

NCT ID: NCT04989751 Enrolling by invitation - LGMD Clinical Trials

A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China

Start date: July 7, 2021
Phase:
Study type: Observational [Patient Registry]

Limb-girdle muscular dystrophies (LGMD) are a series of rare progressive genetic disorders that are characterized by wasting and weakness of the voluntary proximal muscles. The onset of the disease is usually at young age, and most patients will be wheelchair-bound due to the progressive deterioration. Since currently genetic therapies for this disease are still immature, better natural history and genotype-phenotype studies are needed for preparing future therapies.